Understanding daytime functioning in insomnia: responder and correlation analyses in patients treated with daridorexant

Abstract Background Improving daytime functioning is a key treatment goal for patients with insomnia disorder. In a phase 3 study, using the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ), daridorexant 50 mg significantly improved daytime functioning in adults with insomnia, as well as...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pierre-Philippe Luyet, Antonio Olivieri, Guy Braunstein
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2023-09-01
Schriftenreihe:	Sleep Science and Practice
Schlagworte:	Clinically meaningful improvement IDSIQ Insomnia Responders Daytime functioning Responder analysis
Online-Zugang:	https://doi.org/10.1186/s41606-023-00089-x
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!